January 2026
The global fabry disease treatment market size reached USD 2.45 billion in 2025 and is estimated to hit around USD 5.20 billion by 2035 with a CAGR of 7.82%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
March 2026
The global periodontal disease treatment market size was evaluated at USD 2.94 billion in 2025 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
December 2025
The chronic obstructive pulmonary disease treatment market size is expected to hit around USD 33.03 billion by 2035 from USD 21.04 billion in 2025 at a CAGR of 5.14%.
November 2025
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,182.74 million by 2034, growing at a CAGR of 12.04%.
July 2025
The global hearing loss disease treatment market reached USD 14.43 billion in 2024 and is projected to surpass around USD 24.03 billion by 2034 with a CAGR of 5.23%.
June 2025
The global peripheral arterial disease treatment market size is estimated to hit around USD 6.11 billion by 2034 from USD 2.95 billion in 2024, with a CAGR of 7.56%.
July 2025
The global respiratory antiviral treatment market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2025 to 2034.
July 2025
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
June 2025
The global plasma protein therapeutics market size is projcetd to cross around USD 48.43 billion by 2034 from USD 29.56 billion in 2024 with a CAGR of 5.06%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global acne treatment market size was valued at USD 12.37 billion in 2025 and is expected to hit around USD 20.99 billion by 2035, growing at a CAGR of 5.60%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global renal failure treatment market size is accounted to hit around USD 281.02 billion by 2035 increasing from USD 132.28 billion in 2025, with a CAGR of 7.83%.
June 2026
The global lymphoma treatment market size was evaluated at USD 8.08 billion in 2025 and is predicted to hit around USD 17.81 billion by 2035, growing at a CAGR of 8.22%.
June 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 1.99 billion in 2025, with a CAGR of 7.12%.
June 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 2.88 billion in 2025, at a solid CAGR of 6.00%.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 121.01 billion in 2025 with a CAGR of 6.07%.
June 2026
The US diabetic foot ulcer treatment market size was evaluated at USD 3.66 billion in 2025 and is predicted to hit around USD 6.58 billion by 2035, growing at a CAGR of 6.04%.
June 2026
The global chronic smell and flavor loss treatment market size is projected to surge around USD 6.70 billion by 2035 from USD 3.65 billion in 2025 with a CAGR of 6.26%.
June 2026
The global rotator cuff injury treatment market size was evaluated at USD 1.39 billion in 2025 and is predicted to hit around USD 2.35 billion by 2035, growing at a CAGR of 5.37%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The U.S. systemic inflammatory response syndrome treatment market size was evaluated at USD 4.88 billion in 2025 and is predicted to hit around USD 8.83 billion by 2035, growing at a CAGR of 6.11%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com